Insufficient scRNA-seq data for expression of SLC25A15 at single-cell level.
Insufficient scRNA-seq data for expression of SLC25A15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2453.51 | 226 / 226 | 100% | 59.24 | 404 / 406 |
breast | 99% | 176.02 | 455 / 459 | 100% | 17.30 | 1115 / 1118 |
thymus | 100% | 752.53 | 653 / 653 | 98% | 19.30 | 595 / 605 |
pancreas | 100% | 1011.82 | 328 / 328 | 98% | 8.94 | 175 / 178 |
skin | 99% | 300.46 | 1789 / 1809 | 99% | 19.56 | 465 / 472 |
intestine | 97% | 248.65 | 941 / 966 | 100% | 23.43 | 525 / 527 |
stomach | 99% | 184.51 | 354 / 359 | 98% | 19.48 | 281 / 286 |
bladder | 100% | 129.00 | 21 / 21 | 96% | 14.59 | 486 / 504 |
prostate | 99% | 130.65 | 242 / 245 | 97% | 10.72 | 489 / 502 |
esophagus | 96% | 124.03 | 1384 / 1445 | 99% | 12.18 | 181 / 183 |
uterus | 98% | 135.84 | 166 / 170 | 97% | 11.12 | 445 / 459 |
ovary | 98% | 122.97 | 176 / 180 | 95% | 7.50 | 409 / 430 |
brain | 93% | 111.31 | 2447 / 2642 | 99% | 10.48 | 700 / 705 |
lung | 92% | 128.61 | 531 / 578 | 99% | 12.13 | 1148 / 1155 |
kidney | 100% | 234.33 | 89 / 89 | 89% | 6.96 | 803 / 901 |
adrenal gland | 97% | 112.07 | 251 / 258 | 50% | 2.85 | 115 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.75 | 29 / 29 |
spleen | 100% | 121.38 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.25 | 1 / 1 |
adipose | 99% | 123.41 | 1189 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 177.35 | 789 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 9.87 | 44 / 45 |
blood vessel | 96% | 99.49 | 1276 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 11.01 | 75 / 80 |
heart | 85% | 104.71 | 733 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 47% | 146.63 | 437 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903826 | Biological process | L-arginine transmembrane transport |
GO_0000050 | Biological process | urea cycle |
GO_1990575 | Biological process | mitochondrial L-ornithine transmembrane transport |
GO_1903401 | Biological process | L-lysine transmembrane transport |
GO_0016020 | Cellular component | membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0061459 | Molecular function | L-arginine transmembrane transporter activity |
GO_0015189 | Molecular function | L-lysine transmembrane transporter activity |
GO_0000064 | Molecular function | L-ornithine transmembrane transporter activity |
GO_0015297 | Molecular function | antiporter activity |
Gene name | SLC25A15 |
Protein name | Solute carrier family 25 member 15 Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15) |
Synonyms | ORNT1 ORC1 SP1855 |
Description | FUNCTION: Mitochondrial ornithine-citrulline antiporter (Probable). Catalyzes the exchange between cytosolic ornithine and mitochondrial citrulline plus an H(+), the proton compensates the positive charge of ornithine thus leading to an electroneutral transport. Plays a crucial role in the urea cycle, by connecting the cytosolic and the intramitochondrial reactions of the urea cycle (Probable). Lysine and arginine are also transported by the antiport mechanism (Probable). In addition, catalyzes an electroneutral exchange of ornithine or lysine for H(+), a reaction driven by the pH gradient across the inner membrane (By similarity). . |
Accessions | F2Z354 ENST00000470509.1 Q5VZD9 ENST00000417731.5 ENST00000338625.9 Q9Y619 ENST00000707033.1 |